Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction

Detalhes bibliográficos
Autor(a) principal: Sant'Anna,Roberto T.
Data de Publicação: 2003
Outros Autores: Kalil,Renato A. K., Moreno,Paulo, Anflor,Luiz C. J., Correa,Daniel L.C., Ludwig,Roberto, Barra,Marinez B., Silva,Eduardo A., Nardi,Nance, Sant'Anna,João Ricardo M., Prates,Paulo R., Nesralla,Ivo A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000200006
Resumo: OBJECTIVE: Evaluate coronary angiogenic response to transmural injection of plasmid encoding VEGF 165 in acute myocardial infarction (AMI) zones in a canine model. METHODS: The heart of eleven dogs was exposed and AMI was induced by occlusion of the diagonal branch of anterior descending coronary artery. For each of 10 selected points in the infarction area and its peripheral zone injections of 1 ml of saline solution (control group: five dogs) or 1 ml of plasmid encoding VEGF 165 solution (200 µg/ml) (VEGF group: six dogs) were introduced. Tecnecium myocardial scintigraphy was performed immediately after animal recovery and 14 days later to evaluate the myocardial perfusion. The animals were sacrificed and the hearts were submitted to a histological study of the infarcted area, peripheral zone and normal posterior ventricular wall, to evaluate the number of arterioles and capillaries. RESULTS: Immediate modifications in myocardial perfusion found in scintigraphic studies were similar in both groups. In the second evaluation at 14 days, hypoperfusion of ischemic area had recovered by 70% to 90% when compared to the day of AMI. Histologic evaluation of the peripheral area of AMI indicated a larger number of vessels in the VEGF group when compared to controls (mean: 123.81 + 21.48 and 40 + 6.13, p < 0.01, respectively). This increase resulted mainly from an increase in the number of capillaries (97.5 + 16.04 in the VEGF group and 22.18 + 3,25 in control group, p < 0.01), as the number of arterioles did not increase significantly. In the VEGF group, a comparison in the number of vessels of the AMI peripheral area and normal myocardium revealed a non-significant increase of vessels in the ischemic area (123.81 + 21.48 and 95.14 + 41.19). CONCLUSION: An intramural injection of plasmid VEGF 165 resulted in a significant increase in the number of capillaries in the peripheral AMI area. This increase may have a beneficial effect in the reduction and recovery of the ischemic area secondary to AMI.
id SBCCV-1_9e6cc2f1d75a8a68b3293b1d42345e28
oai_identifier_str oai:scielo:S0102-76382003000200006
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarctionGene therapyAngiogenesisVEGFAcute myocardial infarctionOBJECTIVE: Evaluate coronary angiogenic response to transmural injection of plasmid encoding VEGF 165 in acute myocardial infarction (AMI) zones in a canine model. METHODS: The heart of eleven dogs was exposed and AMI was induced by occlusion of the diagonal branch of anterior descending coronary artery. For each of 10 selected points in the infarction area and its peripheral zone injections of 1 ml of saline solution (control group: five dogs) or 1 ml of plasmid encoding VEGF 165 solution (200 µg/ml) (VEGF group: six dogs) were introduced. Tecnecium myocardial scintigraphy was performed immediately after animal recovery and 14 days later to evaluate the myocardial perfusion. The animals were sacrificed and the hearts were submitted to a histological study of the infarcted area, peripheral zone and normal posterior ventricular wall, to evaluate the number of arterioles and capillaries. RESULTS: Immediate modifications in myocardial perfusion found in scintigraphic studies were similar in both groups. In the second evaluation at 14 days, hypoperfusion of ischemic area had recovered by 70% to 90% when compared to the day of AMI. Histologic evaluation of the peripheral area of AMI indicated a larger number of vessels in the VEGF group when compared to controls (mean: 123.81 + 21.48 and 40 + 6.13, p < 0.01, respectively). This increase resulted mainly from an increase in the number of capillaries (97.5 + 16.04 in the VEGF group and 22.18 + 3,25 in control group, p < 0.01), as the number of arterioles did not increase significantly. In the VEGF group, a comparison in the number of vessels of the AMI peripheral area and normal myocardium revealed a non-significant increase of vessels in the ischemic area (123.81 + 21.48 and 95.14 + 41.19). CONCLUSION: An intramural injection of plasmid VEGF 165 resulted in a significant increase in the number of capillaries in the peripheral AMI area. This increase may have a beneficial effect in the reduction and recovery of the ischemic area secondary to AMI.Sociedade Brasileira de Cirurgia Cardiovascular2003-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000200006Brazilian Journal of Cardiovascular Surgery v.18 n.2 2003reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.1590/S0102-76382003000200006info:eu-repo/semantics/openAccessSant'Anna,Roberto T.Kalil,Renato A. K.Moreno,PauloAnflor,Luiz C. J.Correa,Daniel L.C.Ludwig,RobertoBarra,Marinez B.Silva,Eduardo A.Nardi,NanceSant'Anna,João Ricardo M.Prates,Paulo R.Nesralla,Ivo A.eng2005-03-21T00:00:00Zoai:scielo:S0102-76382003000200006Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2005-03-21T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
title Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
spellingShingle Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
Sant'Anna,Roberto T.
Gene therapy
Angiogenesis
VEGF
Acute myocardial infarction
title_short Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
title_full Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
title_fullStr Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
title_full_unstemmed Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
title_sort Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction
author Sant'Anna,Roberto T.
author_facet Sant'Anna,Roberto T.
Kalil,Renato A. K.
Moreno,Paulo
Anflor,Luiz C. J.
Correa,Daniel L.C.
Ludwig,Roberto
Barra,Marinez B.
Silva,Eduardo A.
Nardi,Nance
Sant'Anna,João Ricardo M.
Prates,Paulo R.
Nesralla,Ivo A.
author_role author
author2 Kalil,Renato A. K.
Moreno,Paulo
Anflor,Luiz C. J.
Correa,Daniel L.C.
Ludwig,Roberto
Barra,Marinez B.
Silva,Eduardo A.
Nardi,Nance
Sant'Anna,João Ricardo M.
Prates,Paulo R.
Nesralla,Ivo A.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sant'Anna,Roberto T.
Kalil,Renato A. K.
Moreno,Paulo
Anflor,Luiz C. J.
Correa,Daniel L.C.
Ludwig,Roberto
Barra,Marinez B.
Silva,Eduardo A.
Nardi,Nance
Sant'Anna,João Ricardo M.
Prates,Paulo R.
Nesralla,Ivo A.
dc.subject.por.fl_str_mv Gene therapy
Angiogenesis
VEGF
Acute myocardial infarction
topic Gene therapy
Angiogenesis
VEGF
Acute myocardial infarction
description OBJECTIVE: Evaluate coronary angiogenic response to transmural injection of plasmid encoding VEGF 165 in acute myocardial infarction (AMI) zones in a canine model. METHODS: The heart of eleven dogs was exposed and AMI was induced by occlusion of the diagonal branch of anterior descending coronary artery. For each of 10 selected points in the infarction area and its peripheral zone injections of 1 ml of saline solution (control group: five dogs) or 1 ml of plasmid encoding VEGF 165 solution (200 µg/ml) (VEGF group: six dogs) were introduced. Tecnecium myocardial scintigraphy was performed immediately after animal recovery and 14 days later to evaluate the myocardial perfusion. The animals were sacrificed and the hearts were submitted to a histological study of the infarcted area, peripheral zone and normal posterior ventricular wall, to evaluate the number of arterioles and capillaries. RESULTS: Immediate modifications in myocardial perfusion found in scintigraphic studies were similar in both groups. In the second evaluation at 14 days, hypoperfusion of ischemic area had recovered by 70% to 90% when compared to the day of AMI. Histologic evaluation of the peripheral area of AMI indicated a larger number of vessels in the VEGF group when compared to controls (mean: 123.81 + 21.48 and 40 + 6.13, p < 0.01, respectively). This increase resulted mainly from an increase in the number of capillaries (97.5 + 16.04 in the VEGF group and 22.18 + 3,25 in control group, p < 0.01), as the number of arterioles did not increase significantly. In the VEGF group, a comparison in the number of vessels of the AMI peripheral area and normal myocardium revealed a non-significant increase of vessels in the ischemic area (123.81 + 21.48 and 95.14 + 41.19). CONCLUSION: An intramural injection of plasmid VEGF 165 resulted in a significant increase in the number of capillaries in the peripheral AMI area. This increase may have a beneficial effect in the reduction and recovery of the ischemic area secondary to AMI.
publishDate 2003
dc.date.none.fl_str_mv 2003-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000200006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000200006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-76382003000200006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.18 n.2 2003
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126595020095488